本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Metagenomi Technologies, LLC

1.66
-0.0100-0.60%
成交量:30.92萬
成交額:49.72萬
市值:6,205.66萬
市盈率:-0.70
高:1.71
開:1.70
低:1.55
收:1.67
資料載入中...

公司資料

公司名字:
Metagenomi Technologies, LLC
交易所:
NASDAQ
成立時間:
2016
員工人數:
202
公司地址:
5959 Horton Street,7th Floor,Emeryville,California,United States
郵編:
94608
電話:
傳真:
- -
簡介:
Metagenomi, Inc.於2016年9月在特拉華州註冊成立。該公司是一家精準基因藥物公司,致力於使用專有的、全面的宏基因組學衍生的基因組編輯工具箱為患者開發治療藥物。遺傳病是由一系列不同的突變引起的,這些突變迄今為止在很大程度上是基因組工程方法所無法獲得的。基因突變以多種形式出現,包括缺失、插入、單鹼基對變化和序列重複,在整個基因組中以及在各種不同的細胞類型、組織和器官系統中都有發現。

董事

名稱
職位
Brian C. Thomas
Chief Executive Officer and Director
Jian Irish
President and Chief Operating Officer and Director
Juergen Eckhardt
Director
Sebastián Bernales
Director
Willard Dere
Director

股東

名稱
職位
Brian C. Thomas
Chief Executive Officer and Director
Jian Irish
President and Chief Operating Officer and Director
Alan Brooks
Senior Vice President of Preclinical
Pamela Wapnick
Chief Financial Officer
Simon Harnest
Chief Investment Officer and Senior Vice President of Strategy
Christopher T. Brown
Vice President of Discovery
Luis G. Borges
Chief Scientific Officer
Matthew L. Wein
Vice President of Corporate Legal and Compliance and Corporate Secretary
Michael Conway
Vice President of Finance
Sarah Noonberg
Chief Medical Officer
Simren Delaney
Vice President of Intellectual Property and Legal Operations